Search | IOVS | ARVO Journals

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Pathophysiological roles of adrenomedullin in experimental autoimmune uveitis

Yorishige Matsuda; Shinji Kakihara; Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Megumu Tanaka; Hisaka Kawate; Yunlu Zhao; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2994.

ARVO Annual Meeting Abstract June 2023

Retinal volume assessment using wide-field swept-source optical coherence tomography in eyes without retinal disease

Yoshiaki Chiku; Takao Hirano; Shun Ito; Yoshiaki Takahashi; Ken Hoshiyama; Yasuhiro Iesato; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3700.

ARVO Annual Meeting Abstract June 2023

Investigation of the therapeutic effect of adrenomedullin on experimental autoimmune uveitis

Yorishige Matsuda; Shinji Kakihara; Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Megumu Tanaka; Hisaka Kawate; Zhao Yunlu; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3543.

ARVO Annual Meeting Abstract June 2022

Transcriptome analysis of the pathophysiological significance of adrenomedullin 2 in the mouse choroidal neovascularization model

Shinji Kakihara; Takayuki Sakurai; Akiko Kamiyoshi; Megumu Tanaka; Hisaka Kawate; Yuka Ichikawa-Shindo; Yunlu Zhao; Yorishige Matsuda; Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3875 – A0077.

ARVO Annual Meeting Abstract June 2022

Investigation of the therapeutic effect of adrenomedullin on experimental autoimmune uveitis

Yorishige Matsuda; Shinji Kakihara; Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Megumu Tanaka; Hisaka Kawate; Yunlu Zhao; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3571 – A0458.

ARVO Annual Meeting Abstract June 2021

Pathophysiological roles of adrenomedullin-2 in mouse model of ocular neovascularization

Shinji Kakihara; Masaaki Tanaka; Kazutaka Hirabayashi; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Hisaka Kawate; Yuka Ichikawa-Shindo; Megumu Tanaka; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2946.

ARVO Annual Meeting Abstract June 2021

Changes in retinal sensitivity, thickness, and perfusion density following treatment for branch retinal vein occlusion (BRVO)

Kazutaka Hirabayashi; Srinivas R Sadda; Akira Imai; Yasuhiro Iesato; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3177.

ARVO Annual Meeting Abstract June 2020

The therapeutic potency of exogenous administration of adrenomedullin-2 in ocular neovascular diseases

Shinji Kakihara; Masaaki Tanaka; Kazutaka Hirabayashi; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Hisaka Kawate; Yuka Ichikawa-Shindo; Megumu Tanaka; Kun Dai; Nanqi Cui; Yangxuan Wei; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4937.

ARVO Annual Meeting Abstract July 2019

Correlation between initial visit binocular intraocular pressure difference and mean pulse pressure, and the number of ranibizumab administrations in branch retinal vein occlusion

Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4069.

ARVO Annual Meeting Abstract July 2019

Pathophysiological significance of adrenomedullin-RAMP2 system in age-related macular degeneration

Masaaki Tanaka; Kazutaka Hirabayashi; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Akihiro Yamauchi; Megumu Tanaka; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5382.

ARVO Annual Meeting Abstract July 2018

Investigation of the therapeutic effect of adrenomedullin on central retinal vein occlusion

Kazutaka Hirabayashi; Toshinori Murata; Yasuhiro Iesato; Akira Imai; Yuichi Toriyama; Masaaki Tanaka; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Megumu Tanaka; Akihiro Yamauchi; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4257.

ARVO Annual Meeting Abstract June 2017

Novel mouse model of CRVO induced by intraperitoneal injection of Rose Bengal with laser radiation

Kazutaka Hirabayashi; Yasuhiro Iesato; Akira Imai; Yuichi Toriyama; Sakurai Takayuki; Kamiyoshi Akiko; Yuka Ichikawa-Shindo; Hisaka Kawate; Megumu Tanaka; Akihiro Yamauchi; Toshinori Murata; Shindo Takayuki

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3662.

ARVO Annual Meeting Abstract June 2015

Adrenomedullin reduces VEGF-induced retinal vascular hyperpermeability.

Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Takayuki Shindo; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2296.

ARVO Annual Meeting Abstract April 2014

Pathophysiological roles of endogenous calcitonin gene-related peptide in mouse model of laser induced choroidal neovascularization.

Yuichi Toriyama; Yasuhiro Iesato; Akira Imai; Yuka Ichikawa-Shindo; Akiko Kamiyoshi; Takayuki Sakurai; Takayuki Shindo; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1195.

ARVO Annual Meeting Abstract June 2013

Angiogenic potency of endogenous calcitonin gene-related peptide (CGRP) in mouse model of oxygen-induced retinopathy

Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Takayuki Shindo; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5607.

ARVO Annual Meeting Abstract March 2012

Pathophysiological Role Of Adrenomedullin-ramp2 System In Retinal Neovascularization

Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Shindo; Teruhide Koyama; Takahiro Yoshizawa; Akihiro Yamauchi; Takayuki Shindo; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2999.

ARVO Annual Meeting Abstract April 2011

Angiogenic Potency Of Endogenous Adrenomedullin In Mouse Model Of Oxygen-induced Retinopathy

Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Shido; Teruhide Koyama; Akihiro Yamauchi; Takayuki Shindo; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3166.

NARROW

Content Type

Journal

Article Type

Specify Date Range

Pathophysiological roles of adrenomedullin in experimental autoimmune uveitis

Retinal volume assessment using wide-field swept-source optical coherence tomography in eyes without retinal disease

Investigation of the therapeutic effect of adrenomedullin on experimental autoimmune uveitis

Transcriptome analysis of the pathophysiological significance of adrenomedullin 2 in the mouse choroidal neovascularization model

Investigation of the therapeutic effect of adrenomedullin on experimental autoimmune uveitis

Pathophysiological roles of adrenomedullin-2 in mouse model of ocular neovascularization

Changes in retinal sensitivity, thickness, and perfusion density following treatment for branch retinal vein occlusion (BRVO)

The therapeutic potency of exogenous administration of adrenomedullin-2 in ocular neovascular diseases

Correlation between initial visit binocular intraocular pressure difference and mean pulse pressure, and the number of ranibizumab administrations in branch retinal vein occlusion

Pathophysiological significance of adrenomedullin-RAMP2 system in age-related macular degeneration

Investigation of the therapeutic effect of adrenomedullin on central retinal vein occlusion

Novel mouse model of CRVO induced by intraperitoneal injection of Rose Bengal with laser radiation

Adrenomedullin reduces VEGF-induced retinal vascular hyperpermeability.

Pathophysiological roles of endogenous calcitonin gene-related peptide in mouse model of laser induced choroidal neovascularization.

Angiogenic potency of endogenous calcitonin gene-related peptide (CGRP) in mouse model of oxygen-induced retinopathy

Pathophysiological Role Of Adrenomedullin-ramp2 System In Retinal Neovascularization

Angiogenic Potency Of Endogenous Adrenomedullin In Mouse Model Of Oxygen-induced Retinopathy

To View More...

You must be signed into an individual account to use this feature.